➤ Subscribe for Complete Access

Flexible subscription options to meet your unique needs…

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: November 27, 2021

DrugPatentWatch Database Preview

Patent: 9,206,142

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,206,142
Title:Anilinopiperazine derivatives and methods of use thereof
Abstract: The present invention relates to novel Anilinopiperazine Derivatives of Formula (I), compositions comprising the Anilinopiperazine Derivatives, and methods for using the Anilinopiperazine Derivatives for treating or preventing a proliferative disorder, cancer, an anti-proliferative disorder, inflammation, arthritis, a central nervous system disorder, a cardiovascular disease, alopecia, a neuronal disease, an ischemic injury, a viral disease, a fungal infection, or a disorder related to the activity of a protein kinase. ##STR00001##
Inventor(s): Shipps, Jr.; Gerald W. (Stoneham, MA), Cheng; Cliff C. (Cambridge, MA), Huang; Xiaohua (Malden, MA), Fischmann; Thierry O. (Scotch Plains, NJ), Duca; Jose S. (Cranford, NJ), Richards; Matthew (Somerville, MA), Zeng; Hongbo (Westford, MA), Sun; Binyuan (Chestnut Hill, MA), Reddy; Panduranga Adulla (Walpole, MA), Wong; Tzu T. (Belmont, MA), Tadikonda; Praveen K. (Norwood, MA), Siddiqui; M. Arshad (Newton, MA), Labroli; Marc A. (Moorestown, NJ), Poker; Cory S. (Bridgewater, NJ), Guzi; Timothy J. (Sudbury, MA)
Assignee: Merck Sharp & Dohme Corp. (Rahway, NJ)
Application Number:12/447,712
Patent Claims:see list of patent claims

Details for Patent 9,206,142

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Recordati Rare Diseases, Inc. ELSPAR asparaginase For Injection 101063 1978-01-10 ⤷  Try it Free 2039-02-26
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 1986-06-04 ⤷  Try it Free 2039-02-26
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try it Free 2039-02-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.